Respirics

About:

Respirics is an inhalation drug products company focusing on the development and commercialization of therapeutic products.

Website: http://www.respirics.com

Top Investors: Catalyst Investors, Research Triangle Ventures

Description:

Respirics is an inhalation drug products company focusing on the development and commercialization of therapeutic products using the company's proprietary, customizable Acu-Breatheâ„¢ dry powder inhalers (DPIs). The company's strategy is to develop a suite of inhalation products for asthma and COPD, and to enter licensing and co-development programs with large or specialty pharmaceutical companies.

Total Funding Amount:

$7.65M

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)respirics.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2010-08-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai